C1A
C1A is a class I/II HDACs and sirtuin inhibitor with an IC50 of 479 nM for HDAC6. C1A induces sustained acetylation of HDAC6 substrates, α-tubulin and HSP90. C1A shows srtong anticancer effcts, and induces apoptosis in cancer cells.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 1021463-02-4
- Fòrmula: C22H25Cl2N3O4S
- Peso molecular:498.42
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Descripciòn
IC50 & Target
[1]|
HDAC6 0.48 μM (IC50) |
HDAC8 0.61 μM (IC50) |
HDAC3 5.5 μM (IC50) |
HDAC10 9.8 μM (IC50) |
HDAC2 11 μM (IC50) |
HDAC1 14 μM (IC50) |
HDAC5 15 μM (IC50) |
HDAC4 16 μM (IC50) |
HDAC7 49 μM (IC50) |
HDAC9 56 μM (IC50) |
SIRT3 55 μM (IC50) |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| KMS-11 | GI50 |
0.48 μM
Compound: 22
|
Antiproliferative activity against human KMS-11 cells incubated for 72 hrs by sulphorhodamine B assay
Antiproliferative activity against human KMS-11 cells incubated for 72 hrs by sulphorhodamine B assay
|
[PMID: 29133060] |
| SH-SY5Y | IC50 |
0.28 μM
Compound: 22
|
Antiproliferative activity against human SH-SY5Y cells incubated for 72 hrs by sulphorhodamine B assay
Antiproliferative activity against human SH-SY5Y cells incubated for 72 hrs by sulphorhodamine B assay
|
[PMID: 29133060] |
In Vitro
C1A (2.5-10 μM; 24 h) increases the sub-G1 population in a drug concentration-related manner. And C1A induces apoptosis and inhibits proliferation of a panel of human tumour cell lines from different origins in the low micromolar range[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HCT-116 cells
-
Concentration:2.5 μM, 5 μM, 7.5 μM, 10 μM
-
Incubation Time:24 h
-
Result:Increased the sub-G1 population in a drug concentration-related manner.
-
Cell Line:HCT-116 cells
-
Concentration:0.5 μM, 1 μM, 2.5 μM, 5 μM, 7.5 μM, 10 μM
-
Incubation Time:4 h and 24 h
-
Result:Induced sustained acetylation of HDAC6 substrates, α-tubulin and HSP90.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Female nu/nu-BALB/c mice injected with HCT-116 cells[1]
-
Dosage:20 mg/kg, 40 mg/kg
-
Administration:ip; once a day, twice a day, once every two days; for 14 days
-
Result:Inhibited the growth of colon tumours in vivo.
Chemical Information
-
No. CAS 1021463-02-4
-
Peso molecular 498.42
-
Fòrmula C22H25Cl2N3O4S
-
SMILES
ClCCN(C1=CC=C(C=C1)S(NC2=CC=C(C=C2)/C=C(C)/C=C/C(NO)=O)(=O)=O)CCCl
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)